tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Revenue

Compare
350 Followers

TScan Therapeutics Revenue

TScan Therapeutics had a revenue of 2.57M in the quarter ending Dec 31, 2025, with 2.23%. This bring the company's revenue in the last twelve months to 10.32M, Decreased 22.58%. In the fiscal year ending Dec 31, 2025, TScan Therapeutics had annual revenue of 10.32M with 266.65% growth.
Revenue (ttm)
10.32M
Revenue Growth
-10.03%
P/S Ratio
5.90
Revenue/Employee
$51,625
Employees
200
Market Cap
$60.88M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
10.32M7.51M+266.65%
Dec 31, 2024
2.82M-18.23M-86.62%
Dec 31, 2023
21.05M7.51M+55.52%
Dec 31, 2022
13.54M3.39M+33.47%
Dec 31, 2021
10.14M9.06M+834.65%
Dec 31, 2020
1.08M+∞%
Dec 31, 2019